Preview

Obstetrics, Gynecology and Reproduction

Advanced search

ADVANCED MAGNETIC RESONANCE IMAGING TECHNIQUE IN THE DIAGNOSIS OF OVARIAN LESIONS

https://doi.org/10.17749/2313-7347.2016.10.4.012-020

Full Text:

Abstract

The aim objective: to improve the methods, protocol specification and assessment of the possibilities of the complex magnetic resonance imaging in the diagnosis of ovarian lesions.

Materials and methods. From 2011 to 2015 256 patients with 289 ovarian lesions underwent pelvic and abdominal (if necessary) MRI results compared with histological data, obtained intraoperatively, or verification is made on the basis of dynamic observation for at least 6 months.

Results. Quantitative estimation showed that the amplitude of the accumulation of the contrast agent was significantly higher in malignant tumors – 167% (115.2-212.5%), than benign – 61.2% (41.2-99.0%; P<0.001) and borderline tumors – 85.7% (58.3-138,2%; P<0.01); the period of 1/2 signal intensity rise significantly higher in benign tumors of 35.1 seconds (30.8 seconds and 42.5 seconds) than in the borderline – 27.9 sec (23.5 sec to 29.8 sec; P<0.05), and malignant – 23,1 sec (20.5 h is 30.9 sec; P=0.01). Maximum slope of the contrast enhancement curve (%/sec) amounted to 1.78 (1.0-2.6); 2.86 (2.01-3.95) and 6.1 (4.19-9.46) for benign, borderline and malignant tumors, respectively, and was significantly higher in malignant invasive tumors (P<0.01). The average values of the аpparent diffusion coefficient (ADC) of malignant tumors was significantly lower than the corresponding values in benign (1.012±0.18 mm2 /s×10-3 and 1.54±0.25 mm2 /s×10-3, respectively), the value intervals do not overlap. The threshold value of ADC for malignant ovarian tumors: less 1,139 mm2 /s×10-3. Advanced MRI technique accuracy was 92.1%, with sensitivity of 93.6% and specificity of 91.2%.

Conclusions. Optimization of the technique and protocol standardization of complex MR studies in patients with ovarian lesions provides a complete diagnostic information about the nature, allows if necessary to adequately assess the spread of malignant tumors in primary staging.

About the Authors

A. E. Solopova
FSBEI HE I.M. Sechenov First MSMU MOH Russia
Russian Federation

docent at the Department of Radiology,

ul. Trubetskaya, 8-2, Moscow, 119991



S. K. Ternovoy
FSBEI HE I.M. Sechenov First MSMU MOH Russia
Russian Federation

MD, academician of the Russian Academy of Sciences, Professor, Head of the Department of Radiology,

ul. Trubetskaya, 8-2, Moscow, 119048



E. Z. Mukhamatullina
FSBEI HE I.M. Sechenov First MSMU MOH Russia
Russian Federation

MD, radiologist at the department of computed tomography,

ul. Trubetskaya, 8-2, Moscow, 119991



A. D. Makatsaria
FSBEI HE I.M. Sechenov First MSMU MOH Russia
Russian Federation

MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medical and Preventive,

ul. Trubetskaya, 8-2, Moscow, 119048



References

1. Bakhtiozin R., Safiullin R. Whole-body diffusion-weighted imaging in diagnosis and monitoring of malignant neoplasm treatment. REJR. 2011; 1(2): 13-18.

2. Solopova A.E., Chashchin A.A., Solopova A.G., Makatsariya A.D. Akusherstvo, ginekologiya i reproduktsiya / Obstetrics, gynecology and reproduction. 2016; 10 (3): 52-64.

3. Forstner R., Thomassin-Naggara I., Cunha T.M. et al. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol. 2016 Oct 21PubMed PMID: 27770228.

4. Fujiwara H., Suzuki M. et al. Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer. Japanese women Tumor Biol. 2015; 36: 1045-1053.

5. Ledermann J.A., Raja F.A. et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 2013. Ann Oncol. 2013; 24 (6): vi24-vi32.

6. Medeiros L.R. Accuracy of Ultrasonography With Color Doppler in Ovarian Tumor. A Systematic Quantitative Review International Journal of Gynecological Cancer. February 2009; 19 (2): 230-236.

7. Morgan R.J., Armstrong D.K., Alvarez R.D, Bakkum-Gamez J.N. et al. NCCN Clinical Practice Guidelines in Oncology. Ovarian Cancer, Including Fallopian Tube Cancer and Primary Peritoneal Cancer. 2015; Version 2.

8. Sala E., Kataoka M.Y., Priest A.N., Gill A.B., McLean M.A., Joubert I., Graves M.J., Crawford R.A., Jimenez-Linan M., Earl H.M., Hodgkin C., Griffiths J.R., Lomas D.J., Brenton J.D. Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology. 2012; 263 (1): 149-59. DOI:10.1148/radiol.11110175.

9. Spencer J.A. ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. EurRadiol. 2010; 20: 25-35. 10. Thomassin-Naggara I., Balvay D. et al. Added Value of Assessing Adnexal Masses with Advanced MRI Techniques. BioMed Research International. 2015; Article ID 785206: 10 p.


For citation:


Solopova A.E., Ternovoy S.K., Mukhamatullina E.Z., Makatsaria A.D. ADVANCED MAGNETIC RESONANCE IMAGING TECHNIQUE IN THE DIAGNOSIS OF OVARIAN LESIONS. Obstetrics, Gynecology and Reproduction. 2016;10(4):12-20. (In Russ.) https://doi.org/10.17749/2313-7347.2016.10.4.012-020

Views: 140


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)